The legislative process has already begun and promoting this type of action will be very popular during the election campaign.
Chilean law snuffs out market timer seen as nuisance by industry
A bill requiring that pension advisories register with regulators and hold an insurance policy led to the closure of local pariah Felices y Forrados.
CCR Monthly Approval Report – March 2021
State Street led with eight ETFs approved, followed by Dimensional with two mutual funds, and Axa, BMO, GAM, UBS, and PAI Partners with one product each.
Piñera cracks whip on Congress to avoid third withdrawal from AFPs
The Senate seems unlikely to pass a bill allowing AFPs to touch any additional money flowing from worker paychecks to meet pension obligations.
CCR Monthly Approval Report – February 2021
A total of eight products were added in the month from six different asset managers: Matthews, Eurizon, Allianz, JPMorgan, Genstar Capital and Valor Management.
Andean AFPs hope improving economies will negate need for further withdrawals
A third withdrawal in Chile or in Peru does not have sufficient support at this time but, once the economic effect of the previous withdrawals is over, the situation could change.
CCR Monthly Approval Report – January 2021
HSBC, Aviva Investors, Dimensional, Federated Hermes, Morgan Stanles, Pictet, WisdomTree, Aberdeen Standard and, Berkshire Partners were the managers registering products in January 2021.
Will 2021 be a breakout year for active funds in Mexico? The Amafore seems to think so.
The Amafore's Alvaro Melendez predicted an uptick in allocations to active funds while emphasizing need to increase cap on international investments.
Felices y Forrados in the spotlight as Chilean regulators aim to limit transfers
A government proposal would limit movements between non-adjacent multifunds, while Congress will also examine the role of unregulated advisors.
CCR Monthly Approval Report – December 2020
Columbia Threadneedle led the list of registered products with 14 mutual funds, followed by Samsung with four ETFs, and Aviva, Credit Suisse and Altis each with one product approved of their own.